glp-1 gerd glp 1 and Outpatient Sedation Basics for Patients on Medications Risk of Esophageal and Gastric
Description
A practical approachconsistent with what we know about endometriosis symptom management and the reality of GLP1 GI side effectsis to plan around higher-risk windows: Dose initiation and dose increases are when nausea/vomiting is most likely for many people
3
In a 26-week study of obese and T2DM patients treated with 1.8 mg liraglutide once daily, van Eyk et al demonstrated an average weight loss of 4.3 kg
Once people stop taking these drugs, most seem to regain their lost weight
